Video & Transcript : 'pharmacy school' :

Page 89 of 500
TX
Transcript Highlights:
  • affiliated pharmacies.
  • This is a drug their provider, who went to medical school or nurse practitioner school or PA school,
  • own pharmacies.
  • When I was in pharmacy school, I never once studied a specialty drug. All drugs are special.
  • And they own the specialty pharmacy. Let me guess. a specialty pharmacy.
Keywords: 1185, senate, all
MN

Minnesota 2025-2026 Regular Session

Health Committee Meeting - 2025-04-02

Health Finance and Policy

Transcript Highlights:
  • pharmacies every day.
  • pharmacies at a sustainable rate.
  • This would allow pharmacies serving Medicaid patients to do so and minimize pharmacy deserts.
  • Pharmacies need help now.
  • One is the pharmacy carve-out.
HI

Hawaii 2025 Regular Session

CPC Public Hearing - Wed Apr 2, 2025 @ 2:00 PM HST

Consumer Protection & Commerce

Transcript Highlights:
  • Pharmacy and Rainbow Pharmacy.
  • Pharmacy and Rainbow Pharmacy.
  • Pharmacy and Rainbow Pharmacy.
  • or the local pharmacy.
  • Pharmacy maioli Pharmacy they looked at Pharmacy maioli Pharmacy they looked at their<01:02:30.559><c
Keywords: 910, house, all
Summary: The committee heard several measures, beginning with SB 1046 SD1 on condominiums. Testimony on that bill focused on reserve funding and enforcement of reserve study requirements. The Community Associations Institute opposed the bill, saying it would create hardship, confusion, and be difficult to administer, while also urging stronger penalties for boards that fail to comply with reserve study rules. The Real Estate Commission offered comments, and one testifier spoke in support. No vote was taken during the portion provided. The committee then heard SB 532 SD2 HD1 relating to the Department of Education, which would improve access to pre-approved medications for students with health conditions at school and during off-campus activities. The Department of Health, University of Hawaiʻi nursing and medical programs, and the Department of Education all supported the measure, with DOH suggesting amendments to better identify the correct student and improve medication safety. Members had no questions, and the bill moved on. Next was SB 1245 SD2 HD1 relating to pharmacists, a bill to allow reimbursement for clinical services pharmacists are already trained and licensed to provide. The University of Hawaiʻi, Board of Pharmacy, Walgreens, Mikai Drugs, and the Hawaiʻi Pharmacists Association supported the bill, emphasizing improved access to care, recruitment and retention of pharmacists, and better chronic disease management. The Hawaiʻi Pharmacists Association also discussed proposed amendments to prevent plans from denying coverage or network participation when pharmacists meet credentialing requirements. Members questioned whether insurers would actually use pharmacists and how the bill would affect pay and contracting; no vote was taken in the excerpt. The committee also heard SB 1279 SD2 HD1, another pharmacists bill focused on telepharmacy and 340B-related issues. The Department of Corrections and Rehabilitation supported it, saying telehealth could reduce costs and avoid travel for audits, while the Board of Pharmacy opposed it. Lānaʻi representatives opposed the bill and asked for an exemption, arguing the island already has close in-person access to a resident pharmacist and clinics. The Hawaiʻi Primary Care Association supported the measure, citing large patient savings from 340B pricing, while Mikai Drugs opposed it, arguing that mail-order and telepharmacy are not necessary on some islands and can create delivery and medication-safety problems. Members asked questions about insurer participation, scope of practice, and whether the bill would meaningfully change reimbursement; the transcript ends before any final action or vote.
HI
Transcript Highlights:
  • </c><00:27:54.320><c> I'm</c> Doctor of Pharmacy program. I'm Doctor of Pharmacy program.
  • </c> entry level for practice as a pharmacy entry level for practice as a pharmacy or<00:28:10.880><c
  • However, you have one pharmacy that has served the island for 90 years on Mokai and another pharmacy
  • Pharmacy Solutions LLC, also known as Maui Elola Pharmacy.
  • ,</c><00:41:37.920><c> Maui</c> with the Maui based pharmacy, Maui with the Maui based pharmacy, Maui
Keywords: 910, house, all
Summary: The joint hearing opened with SB 1442, which would update the statute governing the Child and Adolescent Mental Health Division and clarify its role as the state Medicaid provider of intensive mental health services for children and adolescents with serious emotional disturbance. The Department of Health testified in strong support, saying the current statute is outdated and warning against any unfunded mandate because the division relies on federal funding and faces uncertainty about future resources. Written testimony from several organizations also supported the bill. The committees took no immediate action and said they would hold decision-making until later. The hearing then moved to SB 479 on ABLE savings accounts. The Hawaii State Council on Developmental Disabilities and the Hawaii Disability Rights Center supported the measure, arguing that ABLE accounts help people with disabilities save money without losing benefits and that the state needs more outreach and staffing to expand participation. A testifier with a disability said the bill would help people keep Social Security and housing stability. The chair indicated an intention to move the bill forward, and asked about funding; the discussion settled on a requested appropriation of about $75,000 for incentives. Next, SB 1245 on reimbursement of pharmacists drew broad support from the Hawaii Pharmacists Association, rural pharmacies, the Hawaii Primary Care Association, and others, who said the bill would improve access to care, especially on neighbor islands and in rural communities, and help pharmacies participate in 340B-related services. The Insurance Division and HMSA raised concerns about bill language, saying it could be read to cover pharmacists outside an insurer’s network and that the scope of reimbursable services needed clarification; the pharmacists’ association said the bill is intended to apply only to in-network pharmacists and should continue to reference existing scope-of-practice law. The hearing also took up SB 1279, which would allow pharmacists to authorize medications via telehealth under certain circumstances. The State Board of Pharmacy opposed the bill, citing patient safety, a pilot project with reported errors, concerns about controlled substances and unregulated technicians, and the view that in-person pharmacist services are safer and already available on the affected islands. Several pharmacies and health care groups supported the measure as a way to preserve 340B access and improve service on Lānaʻi and Molokaʻi, while some local pharmacies said they already provide in-person service and opposed remote dispensing. No votes were taken in the portion of the hearing provided.
WA

Washington 2025-2026 Regular Session

House Floor Session Mar 6th, 2026

Washington House Floor Meeting

Transcript Highlights:
  • For me, as a high school social studies teacher, I was in charge of the high school and beyond plan in
  • For me, as a high school social studies teacher, I was in charge of the high school and beyond plan in
  • Specialty pharmacy networks all over our nation...
  • Specialty pharmacy networks all over our nation, and the limitations of contract pharmacy, it actually
  • may end up with more pharmacy options or the local pharmacies may become contracted.
Summary: The House took up and passed Second Substitute Senate Bill 5292, which modifies the paid family and medical leave program. Supporters said the bill uses an actuarial model to set rates and maintains a four-month reserve to improve program stability. It passed final passage 95-1. The House then considered Substitute Senate Bill 5841, dealing with completion of course and financial aid-related requirements. An amendment was adopted to add a financial aid calculator and require outreach to students who indicate they have completed a financial aid form, with supporters saying it would help students understand aid eligibility and access college opportunities. The bill then passed as amended, 92-4. The most extensive debate was on Engrossed Second Substitute Senate Bill 5981, concerning the 340B drug pricing program and contract pharmacy relationships. Members offered many amendments seeking to limit the bill’s scope, add transparency, or direct 340B savings toward patient care, low-income patients, rural areas, or charity care; most were rejected. Supporters argued the bill would help safety-net providers, hospitals, and FQHCs, while opponents warned it would mainly benefit large hospital systems, create administrative burdens, and likely face litigation. After the House adopted the committee amendment and rejected the floor amendments, the bill passed 67-30. The transcript then moved on to other business, including Senate messages and the start of debate on House Bill 2487 on taxes, with one technical amendment to clarify taxpayer definitions.
NV
Transcript Highlights:
  • What happens from the pharmacy, you know, from the pharmacy, from the warehouse, to the patient?
  • a pharmacy affiliated with that PBM.
  • So it allows you to use your prescription, your pharmacy. Thank you.
  • This would not apply to indoor workers and or schools.
  • My understanding the school districts already have standards.
Bills: AB93, AB204, AB414, AB504, AB598
MN

Minnesota 2025-2026 Regular Session

House Health Finance and Policy Committee 4/2/25 - Part 1

Health Finance and Policy

Transcript Highlights:
  • </c> targeted to pharmacies in Minnesota. targeted to pharmacies in Minnesota.
  • </c> to do so and minimize pharmacy deserts. to do so and minimize pharmacy deserts.
  • </c> access starts with an open pharmacy. access starts with an open pharmacy.
  • </c> their only pharmacy in 2018. their only pharmacy in 2018.
  • One is the pharmacy carve-out.
Keywords: 1183, house
AL

Alabama 2025 Regular Session

Alabama Senate Banking and Insurance Committee Mar 19th, 2025

Banking and Insurance

Transcript Highlights:
  • Senate Bill 252 regulates the PBM industry, and the Board of Pharmacy regulates the practice of pharmacy
  • school.
  • Previous to owning the pharmacy, I was the last director of pharmacy for the Goodyear Tire and Rubber
  • We found one pharmacy within driving distance of our home, and after school... ...distance of our home
  • that are specialty pharmacies for them, and so. ...that are specialty pharmacies for them.
Keywords: 923, senate, all
MS

Mississippi 2026 Regular Session

MS House Floor - 24 March, 2026; 10:00 AM

Mississippi House Floor Meeting

Transcript Highlights:
  • do for independent pharmacies.
  • </c><00:08:38.440><c> here</c> is the owner of North Town Pharmacy here is the owner of North Town Pharmacy
  • We Pharmacy in Vicksburg, Mississippi.
  • </c> Pharmacy in Batesville. Pharmacy in Batesville. Welcome. Welcome. Welcome.
  • He also serves on the Board of Pharmacy.
CA

California 2025-2026 Regular Session

Assembly Business and Professions Committee Apr 14th, 2026

Business and Professions

Transcript Highlights:
  • Pharmacies like Empower Pharmacy in Houston, Texas.
  • State Board of Pharmacy.
  • pharmacy.
  • pharmacy.
  • I think this witness talked about, the pharmacy and the lack of pharmacy.
Keywords: 988, house, all
ND

North Dakota 2025-2026 Regular Session

Senate Floor Session Apr 16th, 2025 at 12:30 pm

North Dakota Senate Floor Meeting

Transcript Highlights:
  • We have counselors who are within the schools, We have counselors who are within the schools when we
  • with the School for the Blind.
  • This is the second biennium of returning to the Governor's School.
  • School Board Training is our North Dakota legendary school board training, which we've had some good
  • In addition, they own pharmacies and specialty pharmacies and set the terms, conditions, and reimbursement
Keywords: 908, all
Summary: The Senate opened with prayer, the Pledge, a quorum call, and approval of journal corrections. It then handled several House messages, appointing conference committees on Senate Bills 2004 and 2006 and House Bills 1018, 1019, and 1363, and re-referring House Bill 1216 to Appropriations. The chamber also adopted amendments to House Bill 1601, which would have expanded special assistant attorney general authority for certain offices, but the bill failed on final passage after strong opposition centered on preserving the Attorney General’s control and avoiding a solution in search of a problem. A major portion of the day focused on education funding. House Bill 1369 was amended to raise per-pupil aid from 2% and 2% to 3% and 3% and to increase the school construction loan transfer from $75 million to $100 million; supporters said this would help local schools and military base projects, while opponents raised questions about special education placement language and state coordination. The bill passed 44-3. House Bill 1013, the DPI budget, was also amended extensively to adjust staffing, funding sources, grants, meal assistance, teacher training, and other education programs; it passed 45-2. House Bill 2234, dealing with Choice Ready grants, was amended to shift funding away from general funds and toward federal or other sources, but then failed on final passage after the sponsor urged a red vote. The Senate also approved House Bill 1482, restricting bond and indebtedness elections for counties, cities, school districts, and park districts to primary or general election days, and House Bill 1332, creating a value-added agriculture facility incentive program with an emergency clause. House Bill 1010, the Insurance Department budget, passed unanimously after amendments reflecting the merger of the Securities Department into Insurance and adding staff and fee changes, while House Bill 1011, the separate Securities Department budget, failed because its funding was already included in HB 1010. House Bill 1584, a major pharmacy benefit manager reform bill, passed with an enforcement fund and new licensing/enforcement structure despite debate over ERISA and market transparency. In other action, the Senate concurred in House amendments and passed Senate Bills 2226, 2230, 2069, 2082, 2387, 2385, and 2186, with SB 2186 on parenting time interference and a child custody task force passing 27-20 after debate over whether the issue should be left to the courts. Senate Bill 2234, on Choice Ready grants, and Senate Bill 2243, on driver’s license points and traffic penalties, both failed after concurrence motions were adopted but final passage votes were overwhelmingly negative. The chamber also advanced Senate Bill 2291 to conference committee consideration near the end of the transcript.
WA

Washington 2025-2026 Regular Session

House Health Care & Wellness Feb 20th, 2026

Transcript Highlights:
  • contract pharmacies.
  • have pharmacies.
  • they have, and how many of those contract pharmacies... ...how many contract pharmacies they have, how
  • So this is not about the independent pharmacies benefiting or having access to local pharmacies.
  • pharmacies.
Summary: The committee heard public testimony on several health-related bills. SB 5904 would restrict nursing titles such as RN, NP/ARNP, and LPN to licensed human people and prohibit non-human entities, including AI chatbots, from using those titles. The sponsor and nursing advocates said the bill is meant to prevent confusion and protect public trust, while preserving the use of AI as a support tool. SB 5877 would add a $70 surcharge for certified anesthesiologist assistants so they can participate in the Washington Physicians Health Program and access HealWA resources; supporters said it closes a technical gap and aligns CAAs with other medical professions. SB 5185 would create a pilot pathway for certain international medical graduates with clinical experience licenses to obtain full primary care licensure; supporters from the medical commission, physicians, and IMG advocates said the program has worked well, has shown no patient safety issues, and could help address workforce shortages. The committee also heard extensive testimony on ESSB 6210, which would let the Health Benefit Exchange adopt additional market-factor certification criteria for exchange plans, including standards aimed at preserving access and affordability in underserved counties. Supporters, including the exchange, OIC, consumer advocates, tribal representatives, and patient groups, said the bill is needed to respond to federal policy changes, rising premiums, and disappearing coverage in places like San Juan County. Opponents from carriers and employer groups argued the timeline is too fast, the criteria are too discretionary, and the bill could reduce competition and raise costs. The committee then heard SB 5981, which would strengthen protections and reporting requirements for the federal 340B drug pricing program and limit manufacturer restrictions on contract pharmacies and data requests. Hospitals, clinics, and patient advocates said the bill protects safety-net care and rural access, while manufacturers, employers, and business groups argued it would expand a program that already raises costs and lacks transparency. In executive session, the committee took action on SB 5917, related to Department of Corrections distribution of abortion medications, rejecting five proposed amendments and then advancing the bill on a 10-6 vote with three excused. The committee also advanced SB 5988, which concerns Department of Health opioid treatment program accrediting activities, on a do-pass recommendation after brief discussion.
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Financial Services Jun 21st, 2026 at 10:30 am

Joint Committee on Financial Services

Transcript Highlights:
  • As a director of pharmacy, we have six pharmacy sites in Lawrence, Methuen, and Haverhill.
  • pharmacies.
  • pharmacies.
  • of pharmacies.
  • including hospital pharmacies the payers treat 340B pharmacies differently because their pharmacies
Keywords: 995, all
Summary: The committee held a lengthy hearing on a large docket of pharmacy and drug-pricing bills, with most testimony focused on PBM reform, 340B drug discount program protections, specialty medication access, and medication adherence. Chair James Murphy and Senator Paul Feeney opened the hearing and took testimony from legislators, patient advocates, pharmacists, health center leaders, industry representatives, and policy groups. Several speakers described delays, denials, high out-of-pocket costs, and pharmacy closures tied to PBM practices, while others emphasized the importance of community health centers and independent pharmacies in serving patients. On the 340B program, supporters including Senator Eldridge, Senator Payano, Community Care Cooperative, Fenway Health, the Massachusetts League of Community Health Centers, and several community health center leaders argued that bills such as H. 1107 and S. 819 would stop discriminatory PBM and manufacturer practices, preserve contract pharmacy access, and protect safety-net providers that say they reinvest savings into care, pharmacy expansion, interpreter services, behavioral health, and other services. Opponents including PhRMA, the Community Liver Alliance, and a public policy analyst argued the program lacks transparency and accountability, has grown beyond its original purpose, and may benefit large hospitals and for-profit entities more than low-income patients. They urged more reporting and oversight rather than expanding protections. On PBM reform, testimony supported bills including H. 1157, H. 1234, S. 724, S. 831, and related measures that would require rebate pass-through, ban spread pricing, limit steering to PBM-owned pharmacies, and improve reimbursement for community pharmacies. Independent pharmacists and patients said current PBM practices raise costs, create administrative burdens, and threaten access to local pharmacies. PCMA, representing PBMs, opposed the reforms, arguing PBMs lower costs, that plan sponsors choose to contract with them, and that the Health Policy Commission and CHIA should complete their ongoing study before new mandates are adopted. The committee also heard support for H. 1322 and S. 734 on specialty medications, and for H. 781 and H. 1305 on medication synchronization to improve adherence. No votes or formal actions were taken during the hearing.
WA

Washington 2025-2026 Regular Session

House Health Care & Wellness Feb 20th, 2026 at 08:00 am

Health Care & Wellness

Transcript Highlights:
  • contract pharmacies.
  • have pharmacies.
  • It's not the independent pharmacies.
  • So this is not about the independent pharmacies benefiting or having access to local pharmacies.
  • pharmacies.
Bills: SB5877, SB5904, SB5988
CA

California 2025-2026 Regular Session

Assembly Judiciary Committee Jul 15th, 2025

Transcript Highlights:
  • PBMs own health plans, the pharmacy down the street, the mail-order pharmacy to where they steer patients
  • pharmacies to close.
  • Even before the Rite Aid closures, numerous community pharmacies were closing, creating pharmacy deserts
  • and chain pharmacies and affiliate pharmacies.
  • As mentioned, Lincoln Law School is about a third of the tuition of most UC law schools.
Summary: The committee heard testimony on several bills, beginning with SB 41 by Senator Wiener, which would regulate pharmacy benefit managers by increasing transparency, banning patient steering and spread pricing, and requiring full pass-through of rebates. Supporters, including independent pharmacists and health advocates, said PBM practices are driving up drug costs and closing neighborhood pharmacies. Opponents from PBM and health plan groups argued the bill overlaps with recently enacted licensing and reporting requirements, would not lower consumer prices, and may be preempted by ERISA. Members discussed confidentiality issues, consumer savings, and the relationship between SB 41 and the new budget trailer bill; the author asked for an aye vote. The committee then took up SB 378, also by Senator Wiener, aimed at online marketplaces that advertise illegal intoxicating hemp and unlicensed cannabis products. Supporters from labor, public health, and the licensed cannabis industry said online sales are undermining regulated businesses and exposing children to unsafe products. Opponents from tech and hemp industry groups warned the bill is overbroad, could sweep in general-purpose platforms and lawful hemp wellness products, and raises Dormant Commerce Clause and First Amendment concerns. The author said he would narrow the bill, remove industrial hemp references, and address strict liability and standing issues; members largely focused on how to target illegal products without capturing lawful marketplaces. SB 243 by Senator Padilla addressed AI companion chatbots, with supporters including Common Sense Media and transparency advocates warning that these systems can be addictive, manipulative, and dangerous for minors and vulnerable users, citing studies and the death of a Florida teenager. The bill would require disclosures, anti-addiction design limits, self-harm protocols, audits, reporting, and a private right of action. Tech and business groups opposed the measure as overly broad and said its definitions could sweep in general-purpose AI tools; several members supported the goal but questioned the breadth of the definitions and the private right of action. Finally, SB 522 by Senator Wahab would extend just-cause eviction protections to rental units that were previously covered by the Tenant Protection Act but were destroyed in disasters and later rebuilt. Supporters, including Los Angeles city officials and tenant advocates, said the bill would help keep displaced renters housed after wildfires and other disasters. Apartment and realtor groups opposed it, arguing it would remove a key exemption needed to finance rebuilding and could discourage post-disaster reconstruction. Members expressed support for tenant protections in disaster areas, and the author asked for an aye vote.
CA
Transcript Highlights:
  • State Board of Pharmacy.
  • There was a pharmacy that compounded. Now we just have sort of big-brand pharmacy.
  • That was caused by under-reimbursement of pharmacies by pharmacy benefit managers.
  • pharmacy.
  • You're from Keyes Middle School? Yeah. St. Lucie, excuse me. I got the wrong school.
Summary: The Assembly Business and Professions Committee heard a long agenda of bills, with several cannabis-related measures drawing the most testimony. AB 1598 would extend and standardize licensing timelines for behavioral health professionals, AB 1850 would clarify that real estate wholesalers are subject to licensure and disclosure rules, AB 1794 would allow enteral formula to be shipped directly to patients’ homes, and AB 2402 would update an old cap on fees for multi-service health club studios. The committee also heard AB 1990 on compounded GLP-1 drugs, AB 2249 on cannabis packaging attractive to children, AB 2532 on cannabis beverage serving sizes, AB 2537 on prioritizing cannabis enforcement, and AB 1826 on due process protections for cannabis businesses facing embargoes or recalls. Testimony was generally split between public health or consumer-protection advocates and industry representatives. Supporters of the cannabis bills argued for clearer rules, better consumer safety, and more predictable enforcement, while opponents warned that some proposals could overreach, burden compliant businesses, or restrict legitimate branding and access. On AB 1990, supporters said compounded GLP-1 products need stronger testing and truthful advertising, while pharmacists and compounding advocates said existing law already covers much of the conduct and that the bill could create access problems. On AB 2249 and AB 2532, public health witnesses emphasized risks to children and accidental overconsumption, while industry groups sought narrower language and more implementation time. The committee took several roll-call votes after quorum was established. AB 2249, AB 1826, AB 2402, AB 1794, and AB 2532 were all approved and sent to Appropriations, and AB 1826 was sent to Judiciary. The chair and members repeatedly noted accepted committee amendments and, in several cases, said they were prepared to support the bills with those amendments. Some measures were left open or held pending further action as the hearing continued.
WY

Wyoming 2026 Regular Session

Senate Labor, Health & Social Services Committee, February 18, 2026

Labor, Health & Social Services

Transcript Highlights:
  • </c> from the board of pharmacy from the board of pharmacy here?
  • </c> that can happen outside of a pharmacy. that can happen outside of a pharmacy.
  • </c> pharmacy if you're a pharmacist. pharmacy if you're a pharmacist.
  • </c><00:16:22.880><c> individuals,</c><00:16:23.839><c> pharmacy</c> licensed pharmacy individuals, pharmacy
  • </c> pharmacy is making the rules. pharmacy is making the rules. Yes. Yes. Yes.
Bills: HB0143, HB0129
ND

North Dakota 2026 1st Special Session

Joint Policy Jan 21st, 2026 at 01:00 pm

Transcript Highlights:
  • My amendment is not removing public schools; it's removing non-public schools.
  • Only public schools. So what if a private school wants to be part of this?
  • You say only public schools. So what if a private school wants to be a part of this?
  • There is significantly more pharmacology, pharmacokinetics, et cetera, in pharmacy school than medical
  • school.
Keywords: 908, all
Summary: The committee first took up Senate Bill 2401, which would require physicians to complete continuing education on nutrition and metabolic health as part of the state’s rural health transformation effort. HHS supported the bill, saying it would help physicians better address chronic disease and preserve federal grant points tied to the state’s application. A member of the public also testified in favor, arguing that better nutrition education could improve diabetes outcomes and reduce costs. The committee then adopted an amendment to add the Board of Occupational Therapy Practice to the background-check statute so the occupational therapy compact could proceed, and it passed the bill as amended on a roll call vote. The committee next heard House Bill 1621, which would require the Presidential Fitness Physical Fitness Test in elementary, middle, and high school physical education courses. HHS said the bill was part of the rural health transformation application and could help preserve federal funding, but members raised many questions about the test’s criteria, adaptive options for students with disabilities, equipment needs, and whether the bill should apply to non-public schools. Senator Clemens offered an amendment to limit the requirement to public schools, but it failed. Senator Hogan then offered an amendment to clarify exemptions and allow DPI to align implementation with federal guidance; that amendment passed. A further amendment adding language allowing DPI to establish criteria for and exceptions to the test also passed. The committee then approved the bill as amended on a roll call vote. The committee also considered House Bill 1622, which joins North Dakota to the physician assistant licensure compact. HHS said the compact would improve access to care, especially in rural areas, support military families, and help preserve rural health transformation funding. Members noted the compact had been discussed in a prior session and that many earlier concerns had been resolved. After brief discussion about the compact process and its consistency with other interstate compacts, the committee voted to do pass the bill. Finally, the committee began Senate Bill 2402, which expands pharmacists’ prescriptive authority and therapeutic substitution powers. HHS and the Board of Pharmacy supported the bill as a way to improve access to care and maintain rural health transformation funding. Senator Roers introduced a detailed amendment negotiated with the Board of Medicine and Board of Pharmacy to narrow and clarify the bill, including notification requirements, limits on certain drug categories, and patient-protection language for therapeutic substitution. The Board of Pharmacy then testified in support of the broader bill and explained the CLIA-waived testing provisions and the repeal of the older, narrower pharmacist-testing language. The hearing and amendment discussion were still underway when the transcript ended.
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Ways and Means Jun 21st, 2026 at 11:00 am

Joint Committee on Ways and Means

Transcript Highlights:
  • , and we call that a pharmacy desert.
  • , and we call that a pharmacy desert.
  • that if that one pharmacy closed, that area would ...become a pharmacy desert.
  • types of pharmacies?
  • While we have seen a slight decrease in school- and district-wide trainings for school staff, we have
Keywords: 995, all
Summary: The Joint Committee on Ways and Means held a Health and Human Services budget hearing in Clinton, with opening remarks from Chairs Meg Kilcoyne and Robin Kennedy, local officials, and many House and Senate members introducing themselves. The hearing focused on Governor Healey’s FY27 EOHHS and MassHealth budgets, with repeated themes of rising health care costs, federal funding uncertainty, workforce shortages, and access to care in underserved regions. Members also raised concerns about primary care shortages, rural and regional disparities, behavioral health access, maternal health, food insecurity, and the impact of federal policy changes on Massachusetts programs. EOHHS Secretary Kiame Mahaniah said the FY27 EOHHS budget totals $33.7 billion, reflecting mostly non-discretionary growth from health care costs, labor costs, caseload increases, and provider rate pressures. He highlighted targeted investments in foster care, family resource centers, maternal health, youth services, nutrition programs, immigrant legal services, and human service workforce rates, while warning that federal actions could strip roughly $3.5 billion annually from the state’s health care funding. In response to questions, he defended the administration’s cooperation with federal audits and program integrity efforts, discussed the primary care crisis, and said the state is trying to preserve core services while preparing for a more difficult FY28 budget cycle. MassHealth Undersecretary Mike Levine then described two major FY27 challenges: double-digit cost growth and the expected effects of the federal One Big Beautiful Bill Act. He said MassHealth’s proposed $22.7 billion gross budget includes a 7.5% increase and relies on a moratorium on new expansions plus targeted reductions, including a $1,000 annual adult dental cap, ending GLP-1 coverage for weight loss only, reducing care management to peer-state levels, and work groups to slow growth in PCA, adult foster care, and adult day health spending. Members questioned the impact on Boston Health Care for the Homeless, preventive care, and regional access; Levine said the changes are meant to preserve sustainability, that children and certain disabled populations remain protected, and that the administration will continue working with providers, advocates, and the Legislature on implementation and longer-term reforms.
CA
Transcript Highlights:
  • One example that we discussed was students who were enrolled in a school of pharmacy and took very significant
  • So in the situation that I discussed, they used it for purposes of their pharmacy school education, and
  • Pharmacy personnel are trained.
  • We’ve seen pharmacy closures.
  • reflect the distinct roles of hospital inpatient pharmacies versus community pharmacies.
Summary: The joint Assembly and Senate business committees held a sunset review hearing on the California State Board of Pharmacy, with board leadership describing the board’s consumer-protection role and its priorities around access, enforcement, and updating pharmacy law. The board emphasized a proposed shift toward a standard-of-care model for pharmacists, arguing it would reduce rigid protocol requirements and improve access to services such as HIV PrEP/PEP, contraception, and naloxone. Board representatives also discussed pharmacy deserts, possible fee waivers for pharmacies in underserved areas, concerns about payer practices contributing to closures, continuing education audits, and a request to restore more flexibility in licensure decisions and probationary monitoring for applicants with certain criminal histories. A major focus of the hearing was the board’s ongoing compounding regulations, especially the treatment of sterile versus nonsterile compounding and substances such as glutathione and methylcobalamin. The board said the proposal was not a ban on those substances and described the rulemaking as grounded in federal law, USP standards, and public comment, noting the process had gone through multiple modified texts and hearings. Testimony from stakeholders was sharply divided: pharmacists, veterinarians, firefighters, naturopathic doctors, and patient advocates warned the rules were restricting access to compounded medications and harming patients and first responders, while the California Medical Association, psychiatric physicians, and PhRMA raised concerns that the board’s proposals could expand pharmacist authority beyond training, affect physician practice, or create safety risks. Other public comments addressed pharmacy technician ratios, remote processing, flavoring medications, hospital-specific regulation, budget and enforcement transparency, and whether the board should add members with community compounding or pharmacy technician expertise. Committee members also asked about the board’s oversight priorities and the rationale for its standard-of-care proposal. Board staff explained that consumer protection includes education, licensing, policy, and enforcement, with the highest-priority enforcement cases being those posing imminent public harm. After public testimony concluded, the chairs thanked participants and adjourned the sunset review hearing, announcing an immediate transition to the joint informational hearing on the Department of Cannabis Control.